首页|利用Cas9TX实现非病毒TRAC定点整合制备T细胞

利用Cas9TX实现非病毒TRAC定点整合制备T细胞

扫码查看
[目的]Cas9TX是Cas9 的变体,能够显著降低基因编辑过程中染色体易位,大幅提升基因编辑的安全性.研究Cas9TX替换Cas9 实现基因定点敲入的可行性.[方法]首先,利用His标签蛋白纯化技术制备Cas9TX蛋白,并在细胞水平上通过绘制EC50 和核酸酶裂解动力学曲线等进行功能验证.其次,以RNP和dsDNA混合物电转的方式编辑体外激活的T细胞,流式检测定点敲入的效率.最后,探讨了供体模板进行稳定性修饰提升定点敲入效率的可行性.[结果]制备的Cas9TX在T细胞TRAC基因的A、R和S靶点的敲除效率分别为 71.8%、81.0%和 79.9%,具有与Cas9 相当的基因敲除效率.在TRAC 1 号外显子分别设计的dsDNA供体模板(2A-GFP编码序列)和ssDNA供体模板(+GTC bp),发现Cas9TX RNP定点敲入两种模板的效率均显著低于Cas9 RNP.通过DNA修饰制备防TREX2 核酸外切酶降解的供体模板,不能提升Cas9TX RNP定点敲入的效率.[结论]Cas9TX RNP在TRAC三个靶点的基因敲除方面可以替代Cas9 RNP使用,但定点整合外源基因的效率约为Cas9 RNP的一半.为Cas9TX应用于基因定点敲入提供了重要参考.
Generation of Virus-free TRAC-knocked-in T Cells Using Cas9TX
[Objective]Cas9TX,a Cas9 exo-endonuclease,can significantly reduce the chromosomal translocation and greatly improve the safety of gene editing.Thus this work aims to study the feasibility of Cas9TX replacing Cas9 for gene loci knockin.[Method]Firstly,His-tagged Cas9TX protein was prepared and purified.Exo-endonuclease function of Cas9TX was verified using the curves of EC50 and kinetics of nuclease cleavage.Secondly,in vitro activated human T cells were edited via electroporating with Cas9TX RNP and dsDNA.The knockin efficiencies were measured by FACS.Finally,the feasibility of stability-modifications to donor templates for enhancing site-directed knock-in efficiency was explored.[Result]The knock-out efficiencies of the prepared Cas9TX at three TRAC-targeted site A,R and S of the T cells were 71.8%,81.0%and 79.9%,respectively,which were equivalent to that by Cas9.However,the efficiencies of targeted integration of 2A-GFP(dsDNA donor templates designed)or+GTC bp(ssDNA donor templates)into the first exon of TRAC by Cas9TX were much lower than that by Cas9.DNA modifications that inhibit TREX2 exonuclease digestion could not improve the target knock-in efficiency of Cas9TX RNP.[Conclusion]Here we uncovered that Cas9TX RNP may be used for replacement of Cas9 RNP in the gene knock-out in three targets of TRAC,while the targeted integration efficiency using Cas9TX RNP is about half of using Cas9 RNP.This work serves as a valuable reference for using Cas9TX in targeted knock-in strategies.

Cas9TXknock inRNPdsDNACRISPR/Cas9

崔海洋、谭淼、全壮、陈红利、董艳敏、唐立春

展开 >

北京鼎成肽源生物技术有限公司,北京 102200

Cas9TX 定点整合 RNP dsDNA CRISPR/Cas9

北京鼎成肽源生物技术有限公司自筹

Y6

2024

生物技术通报
中国农业科学院农业信息研究所

生物技术通报

CSTPCD北大核心
影响因子:0.505
ISSN:1002-5464
年,卷(期):2024.40(9)